glp-1 drugs overview 2.0: Where the Next Wave of Value Will Be Created GLP-1 Weight Loss Drugs: How

So, when you lose all this fat-free mass where youve got a lot of muscle in there, is that going to, in the long term, cause serious issues

"The pharmacokinetics, pharmacodynamics, safety and tolerability of NN2211, a new long-acting GLP-1 derivative, in healthy men" (PDF)

10.1016/j.jacbts.2021.04.006 178 ShirakawaJ.FujiiH.OhnumaK.SatoK.ItoY.KajiM.et al (2011)

For patients where heart disease is the primary concern alongside weight, the cardiovascular trial evidence behind Wegovy is currently more developed

And the most promising lead in addiction in decades will have come not from a deliberate search but from patients reporting a benefit no one anticipated

These findings support the therapeutic potential of GLP-1RAs in preventing cardiomyocyte injury in conditions such as diabetes, heart failure, and ischemic heart disease, by enhancing cardiomyocyte viability and survival (Mehdi et al